A First Suspected Case of Fibrosing Mediastinitis After Anti-PD-1 Therapy.

Abstract

We describe a first suspected case of fibrosing mediastinitis following anti-programmed death (PD)-1 therapy, pembrolizumab. Multimodality imaging, including cardiac magnetic resonance imaging, and a multidisciplinary team approach were integral to the diagnosis. If further substantiated, systematic surveillance after anti-PD-1 therapy for fibrosing mediastinitis may be warranted. (Level of Difficulty: Intermediate.).

• Authors: Carolyn J Park, Sujethra Vasu, Jean L Urbain, Pierre L Triozzi, Yashashwi Pokharel
• Journal: JACC. Case reports (JACC Case Rep) Vol. 4 Issue 20 Pg. 1363-1365 (Oct 19 2022) ISSN: 2666-0849 [Electronic] Netherlands
• PMID: 36299648 (Publication Type: Journal Article)
• Copyright: © 2022 The Authors.